North America Medical Enzymes Market Forecast 2022-2030
Market Report I 2022-06-21 I 165 Pages I Inkwood Research
KEY FINDINGS
The North America medical enzymes market is predicted to progress with a CAGR of 6.34% during the forecasted period of 2022 to 2030. Some of the top drivers propelling the region's market include the increasing number of chronic conditions, the rise in enzyme therapies, the growing investments in research and development, and the surging awareness about health as well as food and supplements.
MARKET INSIGHTS
The North America medical enzymes market growth assessment constitutes the study of Canada and the United States. Technological developments, in addition to a significant manufacturing capacity as well as strong investments in enzyme advancements, are primarily ascribed to the market growth in Canada. As per a report issued by the World Health Organization (WHO), the two main causes of death in the country are cardiovascular disease and cancer. In this regard, according to the projections by the Canadian Cancer Society, in 2021, 118,200 men in Canada were estimated to be diagnosed with cancer, out of which 44,600 would die. Hence, medical enzymes utilized in the treatment of such diseases are anticipated to observe high demand in Canada.
On the other hand, with the rise in per capita income and improved medical awareness, the expenditure on healthcare is increasing. For instance, according to industry estimates, the gross domestic product per capita in Canada reached $48029.34 in 2021, compared to over $43814 in the previous year. As a result, these factors are set to influence the North America medical enzymes market growth over the forecasted years.
COMPETITIVE INSIGHTS
Key players operating in the market are DuPont, Novus, Codexis, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation cater to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. INCREASED INVESTMENT IN HEALTHCARE RESEARCH AND FACILITIES
3.1.2. WIDENING APPLICATION IN MEDICAL INDUSTRY
3.1.3. GROWING PREVALENCE OF CHRONIC DISEASES AND RISING AGING POPULATION
3.2. KEY RESTRAINTS
3.2.1. HANDLING AND SAFETY OF ENZYMES
3.2.2. REGULATIONS FOR MEDICAL ENZYMES
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON MEDICAL ENZYMES MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
4.6.1. RESEARCH AND DEVELOPMENT
4.6.2. OPERATIONS
4.6.3. OUTBOUND LOGISTICS
4.7. KEY BUYING CRITERIA
4.7.1. COST
4.7.2. QUALITY
4.7.3. APPLICATION
4.8. REGULATORY FRAMEWORK
5. MARKET BY TYPE
5.1. HYDROLASE
5.1.1. HYALURONIDASE
5.1.2. LYSOZYMES
5.1.3. OTHER HYDROLASES ENZYMES
5.2. THROMBOLYTIC
5.2.1. STREPTOKINASE
5.2.2. UROKINASE
5.2.3. OTHER THROMBOLYTIC ENZYMES
5.3. DIGESTIVE ENZYME
5.3.1. LACTASE
5.3.2. L-ASPARAGINASE
5.3.3. OTHER DIGESTIVE ENZYMES
5.4. ENDONUCLEASE
5.4.1. BENZONASE
5.4.2. OTHER ENDONUCLEASES
6. MARKET BY APPLICATION
6.1. DISEASE TREATMENT
6.2. DIAGNOSTIC TOOLS
6.3. BIOMEDICAL RESEARCH
6.4. OTHER APPLICATIONS
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. KEY GROWTH ENABLERS
7.1.3. KEY CHALLENGES
7.1.4. KEY PLAYERS
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED STATES
7.1.5.2. CANADA
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
8.2. COMPANY PROFILES
8.2.1. ADVANCED ENZYMES
8.2.2. AMANO ENZYME
8.2.3. BASF
8.2.4. BBI SOLUTIONS
8.2.5. BRAIN
8.2.6. CODEXIS
8.2.7. CPC BIOTECH
8.2.8. DSM
8.2.9. DUPONT
8.2.10. NOVOZYMES
8.2.11. NOVUS
8.2.12. ROCHE
8.2.13. SANOFI
8.2.14. SEKISUI
8.2.15. THERMO FISHER SCIENTIFIC
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - MEDICAL ENZYMES
TABLE 2: MEDICAL APPLICATION OF VARIOUS ENZYMES
TABLE 3: APPLICATIONS OF ENZYMES IN PHARMACEUTICALS INDUSTRY
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: NORTH AMERICA MEDICAL ENZYMES MARKET, BY TYPE, HISTORICAL YEARS 2018-2021 (IN $ MILLION)
TABLE 6: NORTH AMERICA MEDICAL ENZYMES MARKET, BY TYPE, FORECAST YEARS 2022-2030 (IN $ MILLION)
TABLE 7: NORTH AMERICA MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, HISTORICAL YEARS 2018-2021 (IN $ MILLION)
TABLE 8: NORTH AMERICA MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, FORECAST YEARS 2022-2030 (IN $ MILLION)
TABLE 9: NORTH AMERICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, HISTORICAL YEARS 2018-2021 (IN $ MILLION)
TABLE 10: NORTH AMERICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, FORECAST YEARS 2022-2030 (IN $ MILLION)
TABLE 11: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, HISTORICAL YEARS 2018-2021 (IN $ MILLION)
TABLE 12: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, FORECAST YEARS 2022-2030 (IN $ MILLION)
TABLE 13: NORTH AMERICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, HISTORICAL YEARS 2018-2021 (IN $ MILLION)
TABLE 14: NORTH AMERICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, FORECAST YEARS 2022-2030 (IN $ MILLION)
TABLE 15: NORTH AMERICA MEDICAL ENZYMES MARKET, BY APPLICATION, HISTORICAL YEARS 2018-2021 (IN $ MILLION)
TABLE 16: NORTH AMERICA MEDICAL ENZYMES MARKET, BY APPLICATION, FORECAST YEARS 2022-2030 (IN $ MILLION)
TABLE 17: NORTH AMERICA MEDICAL ENZYMES MARKET, BY COUNTRY, HISTORICAL YEARS 2018-2021 (IN $ MILLION)
TABLE 18: NORTH AMERICA MEDICAL ENZYMES MARKET, BY COUNTRY, FORECAST YEARS 2022-2030 (IN $ MILLION)
TABLE 19: LEADING PLAYERS OPERATING IN NORTH AMERICA MEDICAL ENZYMES MARKET
TABLE 20: LIST OF MERGERS & ACQUISITIONS
TABLE 21: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 22: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 23: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: NORTH AMERICA MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021
FIGURE 8: NORTH AMERICA MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2030 (IN $ MILLION)
FIGURE 9: NORTH AMERICA MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY HYDROLASE ENZYME, IN 2021
FIGURE 10: NORTH AMERICA MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2030 (IN $ MILLION)
FIGURE 11: NORTH AMERICA MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2030 (IN $ MILLION)
FIGURE 12: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 13: NORTH AMERICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 14: NORTH AMERICA MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY THROMBOLYTIC ENZYME, IN 2021
FIGURE 15: NORTH AMERICA MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2030 (IN $ MILLION)
FIGURE 16: NORTH AMERICA MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2030 (IN $ MILLION)
FIGURE 17: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 18: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2030 (IN $ MILLION)
FIGURE 19: NORTH AMERICA MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY DIGESTIVE ENZYME, IN 2021
FIGURE 20: NORTH AMERICA MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2030 (IN $ MILLION)
FIGURE 21: NORTH AMERICA MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2030 (IN $ MILLION)
FIGURE 22: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 23: NORTH AMERICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2030 (IN $ MILLION)
FIGURE 24: NORTH AMERICA MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY ENDONUCLEASE, IN 2021
FIGURE 25: NORTH AMERICA MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2030 (IN $ MILLION)
FIGURE 26: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2030 (IN $ MILLION)
FIGURE 27: NORTH AMERICA MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
FIGURE 28: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2030 (IN $ MILLION)
FIGURE 29: NORTH AMERICA MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2030 (IN $ MILLION)
FIGURE 30: NORTH AMERICA MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2030 (IN $ MILLION)
FIGURE 31: NORTH AMERICA MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 32: NORTH AMERICA MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021& 2030 (IN %)
FIGURE 33: UNITED STATES MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: CANADA MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.